On the one hand, from April 23 to 25, the Cell & Gene on the Mediterranean took place in Barcelona, ​​a two-day conference that, as specified on the official page “”

Dr. Natalia Elizalde, Business Development Director of VIVEbiotech, attended this congress, who held relevant meetings with several renowned “players” of the sector.

Secondly, the following week, between April 29 and May 2, the Annual Meeting of the ASGCT took place in Washington D.C. This event, in words of the Society, “provides an international forum where the latest gene and cell therapy developments are presented and critically discussed. As the leading American conference focusing solely on gene and cell therapy, ASGCT’s annual meeting brings together more than 3,400 professionals including scientists, physicians, and patient advocates“.

VIVEbiotech was an exhibitor in Washington, and on this occasion Dr. Elizalde was accompanied by the Chief Scientific/Technology Officer of VIVEbiotech, Dr. Juan Carlos Ramírez. This event was an excellent opportunity to meet with present and future customers of the company.

The first cycle of congresses will be closed by the World Advanced Therapies & Regenerative Medicine Congress that will begin tomorrow in London.